SCHEMBL20360384

SCHEMBL20360384

NNC(=O)c1cnc2ccccn12

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHB3 P54753 1/20 0.62
NPC1 O15118 6/20 0.55
RAB9A P51151 6/20 0.55
ALDH1A1 P00352 6/20 0.52
GAA P10253 3/20 0.52
KDM4E B2RXH2 2/20 0.52
KMT2A Q03164 1/20 0.52
DDR2 Q16832 4/20 0.52
KIT P10721 3/20 0.52
DDR1 Q08345 3/20 0.52
MAPT P10636 3/20 0.48
CYP1A2 P05177 2/20 0.48
CYP3A4 P08684 1/20 0.48
ROCK1 Q13464 2/20 0.47
ROCK2 O75116 1/20 0.47
ADORA2A P29274 1/20 0.47
SMN1; SMN2 Q16637 5/20 0.47
HPGD P15428 3/20 0.47
GLA P06280 1/20 0.47
GGPS1 O95749 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30552182 0.85 EPHB3 (0.63) EPHB3NPC1RAB9AALDH1A1GAA
SCHEMBL9278491 0.84 EPHB3 (0.59) EPHB3NPC1RAB9AALDH1A1GAA
SCHEMBL9913664 0.84 EPHB3 (0.62) EPHB3NPC1RAB9AALDH1A1GAA
SCHEMBL21387402 0.83 EPHB3 (0.58) EPHB3NPC1RAB9AALDH1A1GAA
SCHEMBL29843826 0.82 EPHB3 (0.56) EPHB3NPC1RAB9AALDH1A1GAA
SCHEMBL2017759 0.81 NPC1 (0.59) EPHB3NPC1RAB9AADORA2A
SCHEMBL16797995 0.81 DDR2 (0.69) EPHB3NPC1RAB9AGAADDR2
SCHEMBL19362092 0.81 EPHB3 (0.55) EPHB3NPC1RAB9AALDH1A1GAA
SCHEMBL20434869 0.81 NPC1 (0.55) EPHB3NPC1RAB9AALDH1A1GAA
Hydrochloric Acid SCHEMBL29440777 0.80 NPC1 (0.57) EPHB3NPC1RAB9AADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10196385-B2 Tetrahydropyranyl benzamide derivatives ELI LILLY AND COMPANY (US) 2019-02-05 US disclosed
US-10196385-B2 Tetrahydropyranyl benzamide derivatives ELI LILLY AND COMPANY (US) 2019-02-05 US disclosed
US-20180194755-A1 Tetrahydropyranyl Benzamide Derivatives ELI LILLY AND COMPANY 2018-07-12 US disclosed
US-20180194755-A1 Tetrahydropyranyl Benzamide Derivatives ELI LILLY AND COMPANY 2018-07-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10196385-B2 Tetrahydropyranyl benzamide derivatives INSR, GPR119, GLP1R EPHB3 2963/4885NPC1 1216/4885RAB9A 1548/4885
US-20180194755-A1 Tetrahydropyranyl Benzamide Derivatives INSR, GPR119, GLP1R EPHB3 2809/4885NPC1 744/4885RAB9A 1509/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.